目的：为临床药师针对心肌梗死二级预防患者开展药学服务、提升其用药依从性提供参考。方法：对我院就诊的200 例

心肌梗死二级预防患者进行问卷调查，按Morisky-Green 评价标准分为用药依从性佳组及用药依从性不佳组，对影响用药依从性

的因素和用药依从性不佳的原因进行统计和分析。结果：共发放调查问卷200 份，回收有效问卷200 份，有效回收率为100％。

137 例受访患者用药依从性佳，63 例受访患者用药依从性不佳，两组受访患者在年龄、月收入、是否有医保、是否独居、口服药物是

否4 种以上等方面有差异，且差异均有统计学意义（P＜0.05）。用药依从性不佳的原因依次是：遗忘用药；口服药物种类过多；药物

昂贵，经济负担过重；对治疗药物认识欠缺，用药指导不到位。结论：心肌梗死二级预防患者用药依从性不佳与高龄、月收入低、无

医保、独居、口服药物4 种以上密切相关。临床药师应发挥其专业特长帮助患者改善用药依从性，同时应进一步完善医疗保险制

度，扩充免费药物的种类，从而提高药物疗效及患者的生存质量。

OBJECTIVE：To provide reference for implementing pharmaceutical care for secondary prevention of patients with

myocardial infarction and improving medication compliance by clinical pharmacist. METHODS：A questionnaire survey was conducted

for 200 secondary prevention patients with myocardial infarction in our hospital，and divided into good medication compliance

group and poor medication compliance group by Morisky-Green（MG）standard scoring evaluation， and the reasons affecting

the medication compliance were statistically analyzed. RESULTS：Totally 200 questionnaires were sent out，200 were effectively received

with effective recovery of 100％. 137 patients showed good medication compliance and 62 patients showed poor medication

compliance，there were statistically significant differences in the age，monthly income，whether there was a medical insurance or

not，whether they live alone or not and whether they had more than 4 oral drugs between 2 groups（P＜0.05）. The reasons of poor

medication compliance were forgetting to take the medicine，too many kinds of medicine，too expensive to afford the medicine，

lacking the knowledge of the disease and poor medication guide. CONCLUSIONS：The poor medication compliance of patients

with secondary prevention of myocardial infarction is closely related with elder age，low income，no medical insurance，living

alone，and taking more than 4 kinds of medicine. Clinical pharmacists should play their professional expertise，repeatedly supervise

patients’medication compliance and finally improve the efficacy and patients’quality of life.